Birth outcomes in pregnant women taking fluoxetine

New England Journal of Medicine

Volumn 335, Issue 14, 1996, Pages 1010-1015

  Chambers, Christina D ^a   Johnson, Kathleen A ^a   Dick, Lyn M ^a   Felix, Robert J ^a   Jones, Kenneth Lyons ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYANOSIS; DEPRESSION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NERVOUSNESS; NEWBORN DISEASE; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS SYNDROME; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY; TREATMENT OUTCOME;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; ADULT; AFFECTIVE SYMPTOMS; BIRTH WEIGHT; CASE-CONTROL STUDIES; FEMALE; FLUOXETINE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; MENTAL DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK; SEROTONIN UPTAKE INHIBITORS;

EID: 0029795224     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199610033351402     Document Type: Article

References (12)

1. Goldstein DJ. Effects of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol 1995;15:417-20.
2. Rosa F. Medicaid antidepressant pregnancy exposure outcomes. Reprod Toxicol 1994;8:444.
3. Pastuszak A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993;269: 2246-8.
4. Marden PM, Smith DW, McDonald MJ. Congenital anomalies in the newborn infant, including minor variations: a study of 4,412 babies by surface examination for anomalies and buccal smear for sex chromatin. J Pediatr 1964;64:357-71.
5. Hollingshead AB. Two factor index of social position. New Haven, Conn.: Yale University Press, 1965.
6. Hamill PVV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979;32:607-29.
7. Walsh-Sukys MC. Persistent pulmonary hypertension of the newborn: the black box revisited. Clin Perinatol 1993;20:127-43.
8. Abrams BF, Laros RK Jr. Pregnancy weight, weight gain, and birth weight. Am J Obstet Gynecol 1986;154:503-9. [Erratum, Am J Obstet Gynccol 1986;155:918.]
9. Leppig KA, Werler MM, Cann CI, Cook CA, Holmes LB. Predictive value of minor anomalies. I. Association with major malformations. J Pediatr 1987;110:531-7.
10. Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 1993;15:414-43.
11. Drug facts and comparisons. 49th ed. St. Louis: Facts and Comparisons, 1995.
12. Vorhces CV, Acuff-Smith KD, Schilling MA, Fisher JE, Moran MS, Buelke-Sam J. A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundam Appl Toxicol 1994;23:194-205.